|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
EP1065207A1
(en)
*
|
1999-07-02 |
2001-01-03 |
Aventis Pharma Deutschland GmbH |
Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
|
|
MXPA02003436A
(es)
*
|
1999-10-07 |
2002-08-20 |
Amgen Inc |
Inhibidores de triazina cinasa.
|
|
DE19948417A1
(de)
*
|
1999-10-07 |
2001-04-19 |
Morphochem Ag |
Imidazol-Derivate und ihre Verwendung als Arzneimittel
|
|
CN1195755C
(zh)
|
1999-12-10 |
2005-04-06 |
่พ็ไบงๅๅ
ฌๅธ |
ๅกๅฏๅนถ[2,3๏ผd]ๅงๅถๅๅ็ฉ
|
|
EP1250137B1
(en)
*
|
2000-01-24 |
2007-08-15 |
Genzyme Corporation |
Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis
|
|
EP1875900A3
(en)
*
|
2000-01-24 |
2010-07-21 |
Genzyme Corporation |
JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis
|
|
MY137020A
(en)
*
|
2000-04-27 |
2008-12-31 |
Abbott Lab |
Diazabicyclic central nervous system active agents
|
|
MXPA03000068A
(es)
*
|
2000-06-26 |
2003-09-25 |
Pfizer Prod Inc |
Compuestos de pirrolo (2,3-d)pirimidina como agentes inmunosupresores.
|
|
US6881737B2
(en)
|
2001-04-11 |
2005-04-19 |
Amgen Inc. |
Substituted triazinyl acrylamide derivatives and methods of use
|
|
US6864255B2
(en)
|
2001-04-11 |
2005-03-08 |
Amgen Inc. |
Substituted triazinyl amide derivatives and methods of use
|
|
US7301023B2
(en)
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
|
KR100875380B1
(ko)
*
|
2001-06-23 |
2008-12-23 |
์๋ฒคํฐ์ค ํ๋ง์ํฐ์นผ์ค ์ธํฌ. |
๋จ๋ฐฑ์ง ํค๋์ ์ต์ ์ ๋ก์์ ํผ๋กค๋กํผ๋ฆฌ๋ฏธ๋
|
|
GB0115393D0
(en)
*
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
|
US7323469B2
(en)
|
2001-08-07 |
2008-01-29 |
Novartis Ag |
7H-pyrrolo[2,3-d]pyrimidine derivatives
|
|
GB0119249D0
(en)
|
2001-08-07 |
2001-10-03 |
Novartis Ag |
Organic compounds
|
|
GT200200234A
(es)
|
2001-12-06 |
2003-06-27 |
|
Compuestos cristalinos novedosos
|
|
US6642381B2
(en)
|
2001-12-27 |
2003-11-04 |
Hoffman-La Roche Inc. |
Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
|
|
DE60305446T4
(de)
|
2002-01-07 |
2009-07-09 |
Eisai R&D Management Co., Ltd. |
Desazapurine und deren verwendung
|
|
GB0202679D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1388541A1
(en)
*
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines as kinase inhibitors
|
|
PL378246A1
(pl)
|
2002-11-26 |
2006-03-20 |
Pfizer Products Inc. |
Sposรณb leczenia odrzucania przeszczepu
|
|
WO2004093812A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Irm Llc |
Compounds that induce neuronal differentiation in embryonic stem cells
|
|
US7169918B2
(en)
*
|
2003-10-27 |
2007-01-30 |
Genelabs Technologies, Inc. |
Methods for preparing 7-(2โฒ-substituted-ฮฒ-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives
|
|
WO2005067546A2
(en)
*
|
2004-01-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
|
|
GB0403606D0
(en)
|
2004-02-18 |
2004-03-24 |
Novartis Ag |
Organic compounds
|
|
EP1750727A2
(en)
*
|
2004-04-23 |
2007-02-14 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
|
AU2005260032A1
(en)
|
2004-06-29 |
2006-01-12 |
Amgen Inc. |
Pyrrolo[2,3-d]pyrimidines that modulate ACK1 and LCK activity
|
|
TW200615268A
(en)
|
2004-08-02 |
2006-05-16 |
Osi Pharm Inc |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen mรฉtodos para su preparaciรณn y sus usos
|
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
FR2880626B1
(fr)
*
|
2005-01-13 |
2008-04-18 |
Aventis Pharma Sa |
Derives de la purine, compositions les contenant et utilisation
|
|
WO2006091450A1
(en)
*
|
2005-02-18 |
2006-08-31 |
Lexicon Genetics Incorporated |
4-piperidin-1-yl-7h-pyrrolo[2,3-d]pyrimidine compounds
|
|
MX2007014066A
(es)
|
2005-05-13 |
2008-02-11 |
Irm Llc |
Compuestos y composiciones como inhibidores de cinasa de proteina.
|
|
JP5071374B2
(ja)
|
2005-07-14 |
2012-11-14 |
ใขในใใฉใน่ฃฝ่ฌๆ ชๅผไผ็คพ |
ใใใญ็ฐใคใในใญใใผใผ๏ผ้ปๅฎณๅค
|
|
EP2251341A1
(en)
|
2005-07-14 |
2010-11-17 |
Astellas Pharma Inc. |
Heterocyclic Janus kinase 3 inhibitors
|
|
CA2621261C
(en)
|
2005-09-22 |
2014-05-20 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
|
EP2532667A1
(en)
*
|
2005-09-30 |
2012-12-12 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of janus kinases
|
|
PT3184526T
(pt)
|
2005-12-13 |
2018-12-19 |
Incyte Holdings Corp |
Derivados de pirrolo[2,3-d]pirimidina como inibidores da cinase janus
|
|
AU2015201850B2
(en)
*
|
2005-12-13 |
2017-03-02 |
Incyte Holdings Corporation |
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
|
|
EP2007767B1
(en)
*
|
2006-03-11 |
2011-11-02 |
Vernalis (R&D) Ltd |
Pyrrolopyrimidine derivatives used as hsp90 inhibitors
|
|
AU2007235487A1
(en)
*
|
2006-04-05 |
2007-10-18 |
Vertex Pharmaceuticals Incorporated |
Deazapurines useful as inhibitors of janus kinases
|
|
GB0608176D0
(en)
*
|
2006-04-25 |
2006-06-07 |
Astex Therapeutics Ltd |
Pharmaceutical Compounds
|
|
DK3421471T3
(da)
*
|
2006-04-25 |
2021-06-14 |
Astex Therapeutics Ltd |
Purin- og deazapurinderivater som farmaceutiske forbindelser
|
|
WO2008012635A2
(en)
*
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Amine derivatives useful as anticancer agents
|
|
EP2061772A4
(en)
*
|
2006-09-11 |
2011-06-29 |
Curis Inc |
MULTIFUNCTIONAL SMALL MOLECULES AS PROLIFERATION-ACTIVE ACTIVE SUBSTANCES
|
|
WO2008033745A2
(en)
*
|
2006-09-11 |
2008-03-20 |
Curis, Inc. |
Fused bicyclic pyrimidines as ptk inhibitors containing a zinc binding moiety
|
|
WO2008075007A1
(en)
*
|
2006-12-21 |
2008-06-26 |
Cancer Research Technology Limited |
Morpholino-substituted bicycloheteroaryl compounds and their use as anti cancer agents
|
|
AR064416A1
(es)
*
|
2006-12-21 |
2009-04-01 |
Cancer Rec Tech Ltd |
Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
|
|
EP2121692B1
(en)
|
2006-12-22 |
2013-04-10 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
|
WO2008084861A1
(ja)
|
2007-01-12 |
2008-07-17 |
Astellas Pharma Inc. |
็ธฎๅใใชใธใณๅๅ็ฉ
|
|
EP2142550A1
(en)
*
|
2007-04-02 |
2010-01-13 |
Palau Pharma, S.A. |
Pyrrolopyrimidine derivatives as jak3 inhibitors
|
|
UA99284C2
(ru)
|
2007-05-11 |
2012-08-10 |
ะะปั ะัะปะปั ะะฝะด ะะพะผะฟะฐะฝั |
ะะะะะะะขะะ ะซ ั70 S6-ะะะะะะซ
|
|
US20080312259A1
(en)
|
2007-06-13 |
2008-12-18 |
Incyte Corporation |
SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
GB0713602D0
(en)
*
|
2007-07-12 |
2007-08-22 |
Syngenta Participations Ag |
Chemical compounds
|
|
EP2185562B1
(en)
*
|
2007-07-27 |
2015-12-02 |
Janssen Pharmaceutica, N.V. |
Pyrrolopyrimidines useful for the treatment of proliferative diseases
|
|
ES2557931T3
(es)
|
2007-08-08 |
2016-01-29 |
Lexicon Pharmaceuticals, Inc. |
(7H-Pirrolo[2,3-d]pirimidin-4-il)-piperazinas como inhibidores de cinasas para el tratamiento de cรกncer e inflamaciรณn
|
|
WO2009030871A1
(en)
*
|
2007-09-07 |
2009-03-12 |
Vernalis R & D Ltd |
Pyrrolopyrimidine derivatives having hsp90 inhibitory activity
|
|
AU2008309383B2
(en)
|
2007-10-11 |
2012-04-19 |
Astrazeneca Ab |
Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors
|
|
EA020777B1
(ru)
|
2007-11-16 |
2015-01-30 |
ะะฝัะฐะนั ะะพัะฟะพัะตะนัะฝ |
4-ะฟะธัะฐะทะพะปะธะป-n-ะฐัะธะปะฟะธัะธะผะธะดะธะฝ-2-ะฐะผะธะฝั, 4-ะฟะธัะฐะทะพะปะธะป-n-ะฟะธัะฐะทะพะปะธะปะฟะธัะธะผะธะดะธะฝ-2-ะฐะผะธะฝั ะธ 4-ะฟะธัะฐะทะพะปะธะป-n-ะฟะธัะธะดะธะปะฟะธัะธะผะธะดะธะฝ-2-ะฐะผะธะฝั ะฒ ะบะฐัะตััะฒะต ะธะฝะณะธะฑะธัะพัะพะฒ ะบะธะฝะฐะท janus
|
|
TWI444382B
(zh)
|
2008-03-11 |
2014-07-11 |
Incyte Corp |
ไฝ็บ๏ฝ๏ฝ๏ฝๆๅถๅไนๆฐฎ้็ฐไธ็ทๅ็ฐไธ็ท่ก็็ฉ
|
|
AU2009239500B2
(en)
|
2008-04-21 |
2014-01-30 |
Lexicon Pharmaceuticals, Inc. |
LIMK2 inhibitors, compositions comprising them, and methods of their use
|
|
JP2011518836A
(ja)
|
2008-04-24 |
2011-06-30 |
ใคใณใตใคใใปใณใผใใฌใคใทใงใณ |
ๅคง็ฐ็ถๅๅ็ฉใใใณใใใใฎใญใใผใผ้ปๅฎณๅคใจใใฆใฎไฝฟ็จ
|
|
PT2384326E
(pt)
|
2008-08-20 |
2014-06-09 |
Zoetis Llc |
Compostos de pirrolo[2,3-d]pirimidina
|
|
US8385364B2
(en)
*
|
2008-09-24 |
2013-02-26 |
Nec Laboratories America, Inc. |
Distributed message-passing based resource allocation in wireless systems
|
|
CL2009001884A1
(es)
*
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composiciรณn que lo comprende para el tratamiento del ojo seco.
|
|
JOP20190231A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
ุทุฑู ูุงุตูุงุญ ู
ุซุจุทุงุช ุงูุฒูู
jak ู ุงูู
ุฑูุจุงุช ุงููุณูุทุฉ ุงูู
ุชุนููุฉ ุจู
|
|
DE102009005193A1
(de)
*
|
2009-01-20 |
2010-07-22 |
Merck Patent Gmbh |
Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren
|
|
WO2010085597A1
(en)
|
2009-01-23 |
2010-07-29 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
|
EP2396004A4
(en)
|
2009-02-11 |
2012-07-25 |
Reaction Biology Corp |
SELECTIVE KINASE HEMMER
|
|
AU2010239396B2
(en)
|
2009-04-20 |
2016-06-23 |
Auspex Pharmaceuticals, Llc |
Piperidine inhibitors of Janus Kinase 3
|
|
ES2487542T3
(es)
*
|
2009-05-22 |
2014-08-21 |
Incyte Corporation |
Derivados de N-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de cinasas Janus
|
|
CN106967070A
(zh)
|
2009-05-22 |
2017-07-21 |
ๅ ๅก็นๆง่กๅ
ฌๅธ |
ไฝไธบjakๆๅถๅ็ๅๅ็ฉ
|
|
CA2767079A1
(en)
*
|
2009-07-08 |
2011-01-13 |
Leo Pharma A/S |
Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
|
|
TWI466885B
(zh)
*
|
2009-07-31 |
2015-01-01 |
Japan Tobacco Inc |
ๅซๆฐฎ่บ็ฐๅๅ็ฉๅๅ
ถ้ซ่ฅ็จ้
|
|
TW201111385A
(en)
*
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
AR078012A1
(es)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus
|
|
AU2010289321A1
(en)
|
2009-09-04 |
2012-04-05 |
The Regents Of The University Of Michigan |
Compositions and methods for treatment of leukemia
|
|
JP5699149B2
(ja)
|
2009-09-04 |
2015-04-08 |
ใใคใชใธใงใณใปใขใคใใใฏใปใจใ ใจใคใปใคใณใณใผใใฌใคใใใ |
๏ผข๏ฝ๏ฝ๏ฝ๏ฝ๏ฝๅใใญใทใณใญใใผใผ้ปๅฎณ่ฌ
|
|
BR112012008267B1
(pt)
|
2009-10-09 |
2022-10-04 |
Incyte Holdings Corporation |
Derivados hidroxila, ceto e glucuronida de 3-(4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1- il)-3-ciclopentilpropanonitrila
|
|
KR20120083452A
(ko)
*
|
2009-10-15 |
2012-07-25 |
ํ์ด์ ์ธ์ฝํฌ๋ ์ดํฐ๋ |
ํผ๋กค๋ก๏ผป2,3-๏ฝ๏ผฝํผ๋ฆฌ๋ฏธ๋ ํํฉ๋ฌผ
|
|
US9074143B2
(en)
*
|
2009-12-11 |
2015-07-07 |
Uop Llc |
Process for producing hydrocarbon fuel
|
|
WO2011075334A1
(en)
|
2009-12-18 |
2011-06-23 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidine compounds
|
|
EP2531508A1
(en)
|
2010-02-05 |
2012-12-12 |
Pfizer Inc. |
Pyrrolo [ 2, 3 - d]pyrimidine urea compounds as jak inhibitors
|
|
CA2790070C
(en)
*
|
2010-02-18 |
2018-03-06 |
Incyte Corporation |
Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
|
|
TWI766281B
(zh)
|
2010-03-10 |
2022-06-01 |
็พๅ่ฑๅก็นๆง่กๅ
ฌๅธ |
ไฝ็บjak1ๆๅถๅไนๅๅถ-4-ๅบไธไบ็ฒไบ่บ่ก็็ฉ
|
|
PE20130216A1
(es)
|
2010-05-21 |
2013-02-27 |
Incyte Corp |
Formulacion topica para un inhibidor de jak
|
|
TW201204732A
(en)
*
|
2010-07-09 |
2012-02-01 |
Leo Pharma As |
Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
|
|
WO2012022045A1
(en)
*
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
|
CN102372717B
(zh)
*
|
2010-08-20 |
2014-06-18 |
ๅ่ฎฐ้ปๅๅป่ฏ๏ผไธๆตท๏ผๆ้ๅ
ฌๅธ |
ๅกๅฏๅนถๅงๅถ็ฑปๅๅ็ฉๅๅ
ถ็จ้
|
|
SG187742A1
(en)
|
2010-08-20 |
2013-03-28 |
Hutchison Medipharma Ltd |
Pyrrolopyrimidine compounds and uses thereof
|
|
TWI401258B
(zh)
*
|
2010-09-08 |
2013-07-11 |
Hutchison Medipharma Ltd |
ๅกๅฏไธฆๅงๅถ้กๅๅ็ฉๅๅ
ถ็จ้
|
|
JP5917544B2
(ja)
|
2010-11-19 |
2016-05-18 |
ใคใณใตใคใใปใใผใซใใฃใณใฐในใปใณใผใใฌใคใทใงใณ๏ผฉ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ
๏ผจ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ ๏ผฃ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ๏ฝ |
๏ผช๏ฝ๏ฝ้ปๅฎณๅคใจใใฆใฎ่ค็ด ็ฐ็ฝฎๆใใญใญใใชใธใณใใใณใใญใญใใชใใธใณ
|
|
AR083933A1
(es)
|
2010-11-19 |
2013-04-10 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
|
US9045485B2
(en)
|
2010-12-16 |
2015-06-02 |
Convergence Pharmaceuticals Limited |
ASK 1 inhibiting pyrrolopyrimidine derivatives
|
|
WO2012088682A1
(en)
*
|
2010-12-29 |
2012-07-05 |
Shanghai Fochon Pharmaceutical Co Ltd. |
2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
|
|
EP2661436B1
(en)
|
2011-01-07 |
2016-04-13 |
Leo Pharma A/S |
Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
|
|
DE102011008352A1
(de)
*
|
2011-01-12 |
2012-07-12 |
Merck Patent Gmbh |
5-([1,2,3]Triazol-4-yl)-7H-pyrrolo-[2,3-d]pyrimidinderivate
|
|
JP5813785B2
(ja)
|
2011-02-04 |
2015-11-17 |
ใใฅใฑใคใณ ใฆใใใผใทใใฃใผ ใชใ ใถ ใใชใผ ในใใชใใ |
ๆใใฅใผใใชใณๆดปๆงใๆใใไบ็ฐๅผใใใณไธ็ฐๅผใฎใใชใใธใณใใญใทใณใญใใผใผ้ปๅฎณๅคใชใใณใซๆฃ่
ใฎๅฆ็ฝฎๆนๆณ
|
|
US9993480B2
(en)
|
2011-02-18 |
2018-06-12 |
Novartis Pharma Ag |
mTOR/JAK inhibitor combination therapy
|
|
US9115133B2
(en)
|
2011-03-22 |
2015-08-25 |
Advinus Therapeutics Limited |
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
|
|
SG193505A1
(en)
|
2011-04-01 |
2013-10-30 |
Astrazeneca Ab |
Therapeutic treatment
|
|
EA201490042A1
(ru)
|
2011-06-20 |
2014-10-30 |
ะะฝัะฐะนั ะะพัะฟะพัะตะนัะฝ |
ะะทะตัะธะดะธะฝะธะป-ัะตะฝะธะป-, ะฟะธัะธะดะธะป- ะธะปะธ ะฟะธัะฐะทะธะฝะธะปะบะฐัะฑะพะบัะฐะผะธะดะฝัะต ะฟัะพะธะทะฒะพะดะฝัะต ะบะฐะบ ะธะฝะณะธะฑะธัะพัั jak
|
|
KR20140034861A
(ko)
*
|
2011-06-29 |
2014-03-20 |
๋จธํฌ ์คํ ์ค๋ ๋ ์ฝํฌ๋ ์ด์
|
๋ํฉํฐ๋ ํฉํฐ๋ค์ -iv ์ต์ ์ ์ ์ ๊ทํ ๊ฒฐ์ ์ง ํํ
|
|
KR20140058543A
(ko)
*
|
2011-07-08 |
2014-05-14 |
๋
ธํ๋ฅดํฐ์ค ์๊ฒ |
์ ๊ท ํผ๋กค๋ก ํผ๋ฆฌ๋ฏธ๋ ์ ๋์ฒด
|
|
WO2013023119A1
(en)
|
2011-08-10 |
2013-02-14 |
Novartis Pharma Ag |
JAK P13K/mTOR COMBINATION THERAPY
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
ไฝ็บ๏ฝ๏ฝ๏ฝๆๅถๅไน็ฐๅทฑๅบๆฐฎ้็ฐไธ็ท่ก็็ฉ
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
ะะฝัะฐะนั ะฅะพะปะดัะฝะณั ะะพัะฟะพัะตะนัะฝ |
ะกะฟะพัะพะฑะธ ั ะฟัะพะผัะถะฝั ัะฟะพะปัะบะธ ะดะปั ะพััะธะผะฐะฝะฝั ัะฝะณัะฑััะพััะฒ jak
|
|
AU2012321110B2
(en)
|
2011-11-30 |
2014-10-23 |
Astrazeneca Ab |
Combination treatment
|
|
US9089574B2
(en)
|
2011-11-30 |
2015-07-28 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
|
EP2788000B1
(en)
*
|
2011-12-06 |
2018-05-30 |
Merck Sharp & Dohme Corp. |
Pyrrolopyrimidines as janus kinase inhibitors
|
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
|
AR091079A1
(es)
|
2012-05-18 |
2014-12-30 |
Incyte Corp |
Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak
|
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
|
CN105732639A
(zh)
*
|
2012-06-29 |
2016-07-06 |
่พ็ๅคง่ฏๅ |
ไฝไธบLRRK2ๆๅถๅ็4-(ๅไปฃ็ๆฐจๅบ)-7H-ๅกๅฏๅนถใ2,3-dใๅงๅถ็ฑป
|
|
AU2013312477B2
(en)
*
|
2012-09-06 |
2018-05-31 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
US9593115B2
(en)
|
2012-09-21 |
2017-03-14 |
Advinus Therapeutics Ltd. |
Substituted fused tricyclic compounds, compositions, and medicinal applications thereof
|
|
US20150284394A1
(en)
*
|
2012-10-26 |
2015-10-08 |
Hoffmann-La Roche Inc. |
Inhibitors of bruton's tyrosine kinase
|
|
CN102936251A
(zh)
*
|
2012-11-05 |
2013-02-20 |
ไธๆตทๆฏๅพๅป่ฏ็งๆๆ้ๅ
ฌๅธ |
ไธ็งๅกๅฏๅนถ[2,3-d]ๅงๅถ่ก็็ฉ็ๅถๅคๆนๆณ
|
|
SG11201503695XA
(en)
|
2012-11-15 |
2015-06-29 |
Incyte Corp |
Sustained-release dosage forms of ruxolitinib
|
|
ES2647525T3
(es)
|
2013-02-22 |
2017-12-22 |
Pfizer Inc. |
Derivados de pirrolo[2,3-d]pirimidina como inhibidores de janus cinasas (JAK)
|
|
HUE057262T2
(hu)
|
2013-03-06 |
2022-04-28 |
Incyte Holdings Corp |
Eljรกrรกs รฉs kรถztitermรฉkek JAK inhibitor elรตรกllรญtรกsรกra
|
|
US9650375B2
(en)
|
2013-03-14 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Indole derivatives useful as anti-diabetic agents
|
|
US9655854B2
(en)
|
2013-08-07 |
2017-05-23 |
Incyte Corporation |
Sustained release dosage forms for a JAK1 inhibitor
|
|
UA117040C2
(uk)
*
|
2013-12-05 |
2018-06-11 |
ะัะฐะนะทะตั ะะฝะบ. |
ะะะ ะะะ[2,3-d]ะะะ ะะะะะะะะ-, ะะะ ะะะ[2,3-b]ะะะ ะะะะะะ- ะขะ ะะะ ะะะ[2,3-d]ะะะ ะะะะะะะะะ ะะะะะะะ
|
|
EP3083618B1
(en)
|
2013-12-17 |
2018-02-21 |
Pfizer Inc |
Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors
|
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
|
JP6585158B2
(ja)
|
2014-08-12 |
2019-10-02 |
ใใกใคใถใผใปใคใณใฏ |
ใคใในใญใใผใผใฎ้ปๅฎณใซๆ็จใชใใญใญ๏ผป๏ผ๏ผ๏ผโ๏ฝ๏ผฝใใชใใธใณ่ชๅฐไฝ
|
|
WO2016040330A1
(en)
|
2014-09-09 |
2016-03-17 |
The Regents Of The University Of Michigan |
Thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
CN105524067A
(zh)
*
|
2014-09-28 |
2016-04-27 |
ๆฑ่ๆฏ่ฒๅนณๅป่ฏ่กไปฝๆ้ๅ
ฌๅธ |
4-ๅไปฃๅกๅฏๅนถ[2,3-d]ๅงๅถๅๅ็ฉๅๅ
ถ็จ้
|
|
CA2984183C
(en)
|
2015-05-01 |
2021-11-09 |
Pfizer Inc. |
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl, pyrrolo[2,3-b]pyridinyl acrylamides and epoxides thereof
|
|
TWI703150B
(zh)
|
2015-06-04 |
2020-09-01 |
็พๅๅบซๆ่
ซ็คๆ่ก่กไปฝๆ้ๅ
ฌๅธ |
็จๆผๆๅถ๏ฝ๏ฝ
๏ฝ๏ฝ๏ฝๅ๏ฝ๏ฝ๏ฝ่็ฝไนไบคไบไฝ็จ็ๆนๆณๅ็ตๅ็ฉ
|
|
US10588907B2
(en)
|
2015-06-04 |
2020-03-17 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with MLL proteins
|
|
AU2016302302B2
(en)
*
|
2015-07-31 |
2019-12-19 |
Taiho Pharmaceutical Co., Ltd. |
Pyrrolo[2,3-d]pyrimidine compound or salt thereof
|
|
KR101771219B1
(ko)
*
|
2015-08-21 |
2017-09-05 |
์์งํํ ์ฃผ์ํ์ฌ |
์ผ๋์ค ํค๋์ 1 ์ ํ์ ์ต์ ์ ๋ฐ ๊ทธ ์์ฝ ์ฉ๋
|
|
JP6873980B2
(ja)
|
2015-09-14 |
2021-05-19 |
ใใกใคใถใผใปใคใณใฏ |
๏ผฌ๏ผฒ๏ผฒ๏ผซ๏ผ้ปๅฎณ่ฌใจใใฆใฎๆฐ่ฆใฎใคใใใพ๏ผป๏ผ๏ผ๏ผโ๏ฝ๏ผฝใญใใชใณใใใณใคใใใพ๏ผป๏ผ๏ผ๏ผโ๏ฝ๏ผฝ๏ผป๏ผ๏ผ๏ผ๏ผฝใใใใชใธใณ่ชๅฐไฝ
|
|
US10045981B2
(en)
|
2015-11-24 |
2018-08-14 |
Jakpharm, Llc |
Selective kinase inhibitors
|
|
CN107098908B
(zh)
*
|
2016-02-23 |
2021-01-08 |
ๆฌฃๅฏๅป่ฏ็งๆ(ไธๆตท)ๆ้ๅ
ฌๅธ |
ไธ็งๅกๅฏๅนถๅงๅถ็ฑปๅๅ็ฉ็ๅถๅคๆนๆณๅๅบ็จ
|
|
CN109640987B
(zh)
|
2016-03-16 |
2022-12-02 |
ๅบๆ่ฟ็คๅญฆๅ
ฌๅธ |
Menin-mll็ๆกฅ่ๅ็ฏๆๅถๅๅไฝฟ็จๆนๆณ
|
|
CN114539284A
(zh)
|
2016-03-16 |
2022-05-27 |
ๅบๆ่ฟ็คๅญฆๅ
ฌๅธ |
็ปๅไปฃ็menin-mllๆๅถๅๅไฝฟ็จๆนๆณ
|
|
CN107513067A
(zh)
|
2016-06-16 |
2017-12-26 |
ๅไบฌ่ตๆๆณฐๅป่ฏๆๆฏๆ้ๅ
ฌๅธ |
ๅซๆๅไปฃ็ฏๆๅบ็ๅกๅฏๅนถๅงๅถๅๅ็ฉ
|
|
CN107513069A
(zh)
*
|
2016-06-16 |
2017-12-26 |
ๆญฃๅคงๅคฉๆด่ฏไธ้ๅข่กไปฝๆ้ๅ
ฌๅธ |
ๆๆงๅกๅฏๅนถๅงๅถๅๅ็ฉ็ๅถๅคๆนๆณ
|
|
SG11201900515PA
(en)
|
2016-07-21 |
2019-02-27 |
Biogen Ma Inc |
Succinate forms and compositions of bruton's tyrosine kinase inhibitors
|
|
WO2018140648A1
(en)
|
2017-01-25 |
2018-08-02 |
Eric Jon Jacobsen |
Pyrrolopyrimidine itk inhibitors for treating inflammation and cancer
|
|
WO2018141842A1
(en)
*
|
2017-02-03 |
2018-08-09 |
Leo Pharma A/S |
5-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NOVEL JAK KINASE INHIBITORS
|
|
EP3601249A4
(en)
|
2017-03-24 |
2020-12-16 |
Kura Oncology, Inc. |
METHODS OF TREATMENT OF MALIGNANT HEMOPATHIES AND EWING'S SARCOMA
|
|
CN108794480A
(zh)
*
|
2017-04-28 |
2018-11-13 |
ๅคฉๆดฅ่ฏ็ฉ็ ็ฉถ้ขๆ้ๅ
ฌๅธ |
ๅกๅฏๅนถๅงๅถ็ฑปๅๅ็ฉใๅ
ถๅถๅคๆนๆณๅ็จ้
|
|
US11542248B2
(en)
|
2017-06-08 |
2023-01-03 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with MLL proteins
|
|
EP3684361A4
(en)
|
2017-09-20 |
2021-09-08 |
Kura Oncology, Inc. |
MENINE-MLL SUBSTITUTE INHIBITORS AND METHODS OF USE
|
|
US10800775B2
(en)
|
2017-11-03 |
2020-10-13 |
Aclaris Therapeutics, Inc. |
Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same
|
|
US10981906B2
(en)
|
2017-11-03 |
2021-04-20 |
Aclaris Therapeutics, Inc. |
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
|
|
AR113922A1
(es)
|
2017-12-08 |
2020-07-01 |
Incyte Corp |
Terapia de combinaciรณn de dosis baja para el tratamiento de neoplasias mieloproliferativas
|
|
CN112105608B
(zh)
|
2018-01-30 |
2023-07-14 |
ๅ ่ต็นๅ
ฌๅธ |
ๅถๅค(1-(3-ๆฐ-2-(ไธๆฐ็ฒๅบ)ๅผ็็ขฑๅบ)ๅๅถ-4-้
ฎ)็ๆนๆณ
|
|
AU2019245420A1
(en)
|
2018-03-30 |
2020-11-12 |
Incyte Corporation |
Treatment of hidradenitis suppurativa using JAK inhibitors
|
|
JP2021534244A
(ja)
|
2018-08-10 |
2021-12-09 |
ใขใฏใฉใชใน ใปใฉใใฅใผใใฃใฏใน๏ผใคใณใณใผใใฌใคใใใ |
ใใญใญใใชใใธใณ๏ฝ๏ฝ๏ฝ้ปๅฎณๅค
|
|
GB201818750D0
(en)
*
|
2018-11-16 |
2019-01-02 |
Institute Of Cancer Res Royal Cancer Hospital |
Lox inhibitors
|
|
CN109394768B
(zh)
*
|
2018-12-10 |
2019-08-23 |
็กไธนๆฑๅปๅญฆ้ข |
ไธ็งๆฒป็ๆนฟ็น็่ฏ็ฉๅๅ
ถๅถๅคๆนๆณ
|
|
EP3946606A1
(en)
*
|
2019-03-27 |
2022-02-09 |
Insilico Medicine IP Limited |
Bicyclic jak inhibitors and uses thereof
|
|
KR20220004726A
(ko)
|
2019-05-02 |
2022-01-11 |
์ดํด๋ผ๋ฆฌ์ค ์๋ผํจํฑ์ค, ์ธ์ฝํฌ๋ ์ดํฐ๋ |
Jak ์ต์ ์ ๋ก์์ ์นํ๋ ํผ๋กค๋กํผ๋ฆฌ๋
|
|
WO2020232247A1
(en)
|
2019-05-14 |
2020-11-19 |
Provention Bio, Inc. |
Methods and compositions for preventing type 1 diabetes
|
|
IL293085A
(en)
|
2019-11-22 |
2022-07-01 |
Incyte Corp |
Combined treatment that includes an alk2 inhibitor and a jak2 inhibitor
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
US12006366B2
(en)
|
2020-06-11 |
2024-06-11 |
Provention Bio, Inc. |
Methods and compositions for preventing type 1 diabetes
|
|
WO2023055731A1
(en)
*
|
2021-09-28 |
2023-04-06 |
Sanford Burnham Prebys Medical Discovery Institute |
Inhibitors of serine/threonine protein kinase stk3 or stk4 and uses thereof
|